Laura J Chambers, DO, MS, BA
Academic Title: Assistant Professor in the College of Medicine
Research Program: Translational Therapeutics
About Me
More info forMy research is focused on the role of the gut and female reproductive tract microbiota in gynecologic cancer development, response to treatment and as a potential therapeutic target. To support this research, I have authored or co-authored more than 50 articles in such peer-reviewed scientific journals as Gynecologic Oncology, American Journal of Obstetrics and Gynecology, Obstetrics and Gynecology, Journal of Minimally Invasive Gynecologic Oncology and the International Journal of Gynecologic Cancer.
Clinical Expertise
More info for- Cervical Cancer
- Gynecologic Cancers
- Vaginal Cancers
- Ovarian Cancers
- Vulvar Cancers
- Uterine Cancers
Where I See Patients
More info forThe Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
460 W. 10th Ave. Columbus, Ohio 43210 800-293-5066 Location InformationEducation & Training
More info forFellowship - Fellow
- Cleveland Clinic Foundation
Cleveland, OH
USA
Residency - Resident
- Cleveland Clinic Foundation
Cleveland, OH
USA
Fellowship - Resident Fellow
- University of Texas MD Anderson Cancer Center
Houston, TX
USA
Medical Degree - DO
- Chicago College of Osteopathic Medicine
Downers Grove, IL
USA
Graduate Program - MS
- Midwestern University
Downers Grove, IL
USA
Undergraduate Degree - MA
- University of Illinois
Urbana, IL
USA
- Cleveland Clinic Foundation
Academic Office & Contact Information
More info forAcademic Office:
Starling Loving Hall
320 W 10th Ave
Columbus, Ohio 43210-1280Email:
laura.chambers@osumc.eduPublications
More info forAugust 7, 2024Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: A review for the gynecologic oncologist.
Riedinger CJ, Sakach J, Maples JM, Fulton J, Chippior J, O'Donnell B, O'Malley DM, Chambers LM
Gynecol Oncol
August 1, 2024Postoperative venous thromboembolism risk in patients with vulvar carcinoma: An analysis of the National surgical Quality Improvement Program (NSQIP) database.
Kistenfeger Q, Felix AS, Meade CE, Wagner V, Bixel K, Chambers LM
Gynecol Oncol Rep
May 6, 2024Assessment of socioeconomic and racial differences in patients undergoing concurrent gynecologic oncology and urogynecology surgeries: a National Inpatient Sample (NIS) database study.
Marcu I, McLaughlin EM, Nekkanti S, Khadraoui W, Chalif J, Fulton J, O'Malley D, Chambers LM
Int J Gynecol Cancer
April 25, 2024Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-Oncology Research.
Chambers L, Haight P, Chalif J, Mehra Y, Spakowicz D, Backes FJ, Cosgrove CM, O'Malley DM, Vargas R, Corr BR, Bae-Jump VL, Arend RC
Clin Cancer Res
April 1, 2024Retraction notice to "Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer" [Gynecologic Oncology 183 (2024) 78-84].
Riedinger CJ, Barrington DA, Nagel CI, Khadraoui WK, Haight PJ, Tubbs C, Backes FJ, Cohn DE, O'Malley DM, Copeland LJ, Chambers LM
Gynecol Oncol
March 29, 2024Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer.
Riedinger CJ, Barrington DA, Nagel CI, Khadraoui WK, Haight PJ, Tubbs C, Backes FJ, Cohn DE, O'Malley DM, Copeland LJ, Chambers LM
Gynecol Oncol
February 29, 2024Diagnosis and management of gastric-type endocervical adenocarcinoma: A case report and review of the literature.
Chalif J, Kistenfeger Q, Fulton J, Morton M, DeVengencie I, Weldemichael W, Vazzano J, O'Malley DM, Chambers LM
Gynecol Oncol
January 22, 2024Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.
Levine MD, Wang H, Sriram B, Khan A, Senter L, McLaughlin EM, Bixel KL, Chambers LM, Cohn DE, Copeland LJ, Cosgrove CM, Nagel CI, O'Malley DM, Backes FJ
Gynecol Oncol
December 7, 2023The microbiome and gynecologic cancer: cellular mechanisms and clinical applications.
Chalif J, Wang H, Spakowicz D, Quick A, Arthur EK, O'Malley D, Chambers LM
Int J Gynecol Cancer
September 21, 2023The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer.
Haight PJ, Kistenfeger Q, Riedinger CJ, Khadraoui W, Backes FJ, Bixel KL, Copeland LJ, Cohn DE, Cosgrove CM, O'Malley DM, Nagel CI, Spakowicz DJ, Chambers LM
Gynecol Oncol
June 15, 2023"More than a song and dance": Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok.
Morton M, Haight PJ, Khadraoui W, Backes F, Bixel K, O'Malley DM, Nagel C, Chambers LM
Gynecol Oncol
April 1, 2023Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer.
Piver RN, Wagner VM, Levine MD, Backes FJ, Chambers LJ, Cohn DE, Copeland LJ, Cosgrove CM, Nagel CI, O'Malley DM, Bixel KL
Gynecol Oncol Rep
March 10, 2023The modified 5-item frailty index is a predictor of post-operative complications in vulvar cancer: a National Surgical Quality Improvement Program (NSQIP) analysis.
Levine MD, Felix AS, Meade CE, Bixel KL, Chambers LM
Int J Gynecol Cancer
December 24, 2022Postoperative Venous Thromboembolism Risk Stratification in Patients with Uterine Cancer.
Wagner VM, Piver RN, Levine MD, Backes FJ, Chambers LJ, Cohn DE, Copeland LJ, Cosgrove CM, Nagel CI, O'Malley DM, Bixel KL
Am J Obstet Gynecol